Skip to content
Fiscal Receipts

Senate LDA lobbying filing

PFIZER, INC.

Registrant: AVOQ, LLC Year: 2024 Period: First Quarter Type: 1A

View on lda.senate.gov ↗

Reported income

$50.0K

Reported expenses

not reported

Tracked program mentions1

Quoted activity text is clipped to a short extract; each filing’s full description is under Lobbying activities below.

Lobbying activities3

  • Health IssuesHCR

    General health issues; H.R. 4307/S. 2115, Medical Supply Chain Resiliency Act; H.R. 7174, To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program

  • Taxation/Internal Revenue CodeTAX

    Issues related to the Vaccine Injury Compensation Program

  • Trade (domestic/foreign)TRD

    Issues related to a Trade-Related Aspects of Intellectual Property Rights (TRIPS) waiver for COVID-19 therapeutics

Lobbyists3

  • BILL GHENT
  • SANDRA ALCALA
  • STEVEN ELMENDORF

Source: U.S. Senate Lobbying Disclosure Act database. Dollar figures (underlined) cite the filing record on lda.senate.gov — click to view the citation. Amounts shown as “not reported” are absent from the filing itself.